• No results found

Ursodeoxycholic acid (UDCA)

QUANTITATIVE ESTIMATION AND VALIDATION OF URSODEOXYCHOLIC ACID TABLETS BY RP HPLC

QUANTITATIVE ESTIMATION AND VALIDATION OF URSODEOXYCHOLIC ACID TABLETS BY RP HPLC

... Ursodeoxycholic acid is an epimer of chenodeoxycholic ...bile acid found first in the bear1 and is apparently either a precursor or a product of ...aceton2 Ursodeoxycholic acid is found ...

21

Ursodeoxycholic acid attenuates colonic epithelial secretory function

Ursodeoxycholic acid attenuates colonic epithelial secretory function

... cholic acid (CA) and chenodeoxycholic acid (CDCA) are synthesised in the liver, stored in their conjugated forms in the gallbladder and released into the duodenum upon ingestion of ...Cholic acid is ...

12

Preparation of ursodeoxycholic acid from 7-ketone lithocholic acid by stereoselective electroreduction

Preparation of ursodeoxycholic acid from 7-ketone lithocholic acid by stereoselective electroreduction

... of UDCA could be ...of UDCA could be obtained by catalytic hydrogenation of 3α-hydroxy-7-oxo-5β-cholanate using Raney nickel as the catalyst and beta-branched alcohols as the solvent in the presence of a ...

9

The role of Ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review

The role of Ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review

... Ursodeoxycholic acid (UDCA), a secondary bile acid produced by intestinal bacteria as metabolic by product, has been shown effective in the non-surgical treatment of cholesterol gallstones and ...

8

Separation of ursodeoxycholic acid by silylation crystallization

Separation of ursodeoxycholic acid by silylation crystallization

... Ursodeoxycholic acid was purified by silylation crystallization in this ...of ursodeoxycholic acid was up to ...deoxycholic acid. Compared with previous methods, the UDCA ...

8

RP HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF SILIBININ AND URSODEOXYCHOLIC ACID IN BULK AND IN THEIR COMBINED TABLET DOSAGE FORM

RP HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF SILIBININ AND URSODEOXYCHOLIC ACID IN BULK AND IN THEIR COMBINED TABLET DOSAGE FORM

... Ursodeoxycholic acid (UDCA) is an epimer of chenodeoxycholic acid and is a mammalian bile acid found first in the ...[7] UDCA is a white, odorless, crystalline powder with a ...

9

Massimo Milani UrsodeoxycholicAcid(UDCA) inBiliaryDiseases:AClinicalReview British Journal of Medicine & Medical Research

Ursodeoxycholic Acid (UDCA) in Biliary Diseases: A Clinical Review

... of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric ...trial. UDCA- Cooperative Group from the Spanish Association for the Study of the ...

8

Game and Players: Mitochondrial Apoptosis and the Therapeutic Potential of Ursodeoxycholic Acid

Game and Players: Mitochondrial Apoptosis and the Therapeutic Potential of Ursodeoxycholic Acid

... that ursodeoxycholic acid (UDCA), an endogenous hydrophilic bile acid, is a potent inhibitor of apoptosis by either stabilizing the mitochondrial membrane or modulating the expression of ...

17

Ursodeoxycholic Acid Improves Mitochondrial Function and Redistributes Drp1 in Fibroblasts from Patients with either Sporadic or Familial Alzheimer's Disease

Ursodeoxycholic Acid Improves Mitochondrial Function and Redistributes Drp1 in Fibroblasts from Patients with either Sporadic or Familial Alzheimer's Disease

... aggregations. Ursodeoxycholic acid (UDCA), a treatment for primary biliary cirrhosis, improves mitochondrial function in fibroblasts derived from Parkinson's disease patients as well as several ...

13

Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity

Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity

... Background: Ursodeoxycholic acid (UDCA) is used to treat primary biliary cirrhosis, intrahepatic cholestasis, and other cholestatic ...of UDCA remains ...effects, UDCA was reported to ...

12

Thermal Decomposition Kinetics of Ursodeoxycholic Acid Drug Crystal

Thermal Decomposition Kinetics of Ursodeoxycholic Acid Drug Crystal

... TGA/DTA plot is presented in Figure 2. TGA/DTA of ursodeoxycholic acid showed no appreciable mass loss before the melting point (200.6˚C) which rea- sonably agrees with the literature value [14]. Absence of ...

6

Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid

Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid

... chenodeoxycholic acid, 43%; deoxycholic acid, 11%, and lithocholic acid, ...chenodeoxycholic acid therapy increased the proportion of this bile acid to approximately 80% and decreased ...

11

A comparative study of the treatment outcomes in Alcoholic Liver Disease patients treated with Ursodeoxycholic acid and Methionine along with Abstinence (Placebo)

A comparative study of the treatment outcomes in Alcoholic Liver Disease patients treated with Ursodeoxycholic acid and Methionine along with Abstinence (Placebo)

... of ursodeoxycholic acid (300mg),methionine (400mg)and abstinence in the treatment of alcoholic liver disease and the objective is to achieve the following end points(primary end point -change from baseline ...

8

DEVELOPMENT AND VALIDATION OF RP HPLC METHOD TO DETERMINE URSODEOXYCHOLIC ACID IN PHARMACEUTICAL DOSAGE FORMS

DEVELOPMENT AND VALIDATION OF RP HPLC METHOD TO DETERMINE URSODEOXYCHOLIC ACID IN PHARMACEUTICAL DOSAGE FORMS

... of ursodeoxycholic acid used to solubilize cholesterol gallstones, in conventional tablet dosage formulation and in prepared dosage ...condition ursodeoxycholic acid was eluted about ...

6

Effect of Ursodeoxycholic Acid on Liver Function in Children After Successful Surgery for Biliary Atresia

Effect of Ursodeoxycholic Acid on Liver Function in Children After Successful Surgery for Biliary Atresia

... of UDCA treatment (T0) was ...with UDCA for a median of ...the UDCA treatment, no other modifications were made to medical treatment during the ...of UDCA treatment were observed at the start ...

8

Pretreatment with Ursodeoxycholic Acid (UDCA) as a Novel Pharmacological Intervention in Hepatobiliary Scintigraphy

Pretreatment with Ursodeoxycholic Acid (UDCA) as a Novel Pharmacological Intervention in Hepatobiliary Scintigraphy

... use. UDCA has been used in patients with chole- stasis and in people with indigestion, and the dose (200 mg) of the UDCA used in this study is considered relatively ...if UDCA pretreatment for ...

5

Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis

Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis

... The studies included in this study fit the following three cri- teria. First, in terms of study design, randomized controlled trials (RCTs) comparing combination therapy with UDCA/ fenofibrate and monotherapy with ...

10

Defining the Dynamics Between the Gut Microbiota, Microbial Derived Secondary Bile Acid Ursodeoxycholic Acid (UDCA), and Clostridioides difficile Pathogenesis.

Defining the Dynamics Between the Gut Microbiota, Microbial Derived Secondary Bile Acid Ursodeoxycholic Acid (UDCA), and Clostridioides difficile Pathogenesis.

... Fig. 1. A: Production of microbial derived secondary bile acids. Primary bile acids, chenodeoxycholate (CDCA) and cholate (CA) are synthesized from cholesterol by hepatocytes in humans and rodents. In rodents, a portion ...

257

Bile Acid Analysis in Biliary Tract Cancer

Bile Acid Analysis in Biliary Tract Cancer

... cholic acid (CA), chenodeo- xycholic acid (CDCA), deoxycholic acid (DCA), lithocholic acid (LCA), and ursodeoxycholic acid (UDCA) were ...each acid was made by ...

9

Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit

Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit

... Two infants with extreme phenotypes were excluded: (1) a preterm, IUGR infant with congenital diaphrag- matic hernia who died on extracorporeal membrane oxygenation (ECMO) at day 14 with[r] ...

6

Show all 10000 documents...

Related subjects